Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS have developed a new method that allows ...
Led by CEO Harry Rowland, VahatiCor is developing the A-Flux coronary sinus reducer implant for coronary microvascular dysfunction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results